Ahmad Abou Tayoun

ORCID: 0000-0002-9134-1673
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Rare Diseases
  • Genomic variations and chromosomal abnormalities
  • SARS-CoV-2 and COVID-19 Research
  • Hearing, Cochlea, Tinnitus, Genetics
  • Cancer Genomics and Diagnostics
  • Genomics and Phylogenetic Studies
  • RNA modifications and cancer
  • COVID-19 Clinical Research Studies
  • interferon and immune responses
  • Genetics and Neurodevelopmental Disorders
  • Genetic factors in colorectal cancer
  • Immunodeficiency and Autoimmune Disorders
  • Prenatal Screening and Diagnostics
  • Inflammasome and immune disorders
  • Neurogenetic and Muscular Disorders Research
  • Kawasaki Disease and Coronary Complications
  • BRCA gene mutations in cancer
  • Respiratory viral infections research
  • Biomedical Text Mining and Ontologies
  • Genetic Associations and Epidemiology
  • CRISPR and Genetic Engineering
  • Diabetes and associated disorders
  • Ear Surgery and Otitis Media
  • Molecular Biology Techniques and Applications
  • Chromosomal and Genetic Variations

Mohammed Bin Rashid University of Medicine and Health Sciences
2020-2025

Al Jalila Foundation
2018-2025

University of Medicine and Health Sciences
2023-2024

Children's Specialty Group
2018-2024

Children's Hospital of Philadelphia
2015-2024

Medical University of Vienna
2021

University of Pennsylvania
2015-2020

Dartmouth College
2009-2019

Philadelphia University
2016

Dartmouth–Hitchcock Medical Center
2012-2015

The 2015 ACMG/AMP sequence variant interpretation guideline provided a framework for classifying variants based on several benign and pathogenic evidence criteria, including criterion (PVS1) predicted loss of function variants. However, the did not elaborate specific considerations different types variants, nor it provide decision-making pathways assimilating information about type, its location, or any additional likelihood true null effect. Furthermore, this take into account relative...

10.1002/humu.23626 article EN Human Mutation 2018-09-07
Wen‐Wei Liao Mobin Asri Jana Ebler Daniel Doerr Marina Haukness and 95 more Glenn Hickey Shuangjia Lu Julian Lucas Jean Monlong Haley Abel Silvia Buonaiuto Xian Chang Haoyu Cheng Justin Chu Vincenza Colonna Jordan M. Eizenga Xiaowen Feng Christian Fischer Robert S. Fulton Shilpa Garg Cristian Groza Andrea Guarracino William T. Harvey Simon Heumos Kerstin Howe Miten Jain Tsung-Yu Lu Charles Markello Fergal J. Martin Matthew W. Mitchell Katherine M. Munson Moses Njagi Mwaniki Adam M. Novak Hugh E. Olsen Trevor Pesout David Porubský Pjotr Prins Jonas A. Sibbesen Jouni Sirén Chad Tomlinson Flavia Villani Mitchell R. Vollger Lucinda Antonacci-Fulton Gunjan Baid Carl Baker Anastasiya Belyaeva Konstantinos Billis Andrew Carroll Pi-Chuan Chang Sarah Cody Daniel E. Cook Robert Cook‐Deegan Omar E. Cornejo Mark Diekhans Peter Ebert Susan Fairley Olivier Fédrigo Adam L. Felsenfeld Giulio Formenti Adam Frankish Yan Gao Nanibaa’ A. Garrison Carlos García Girón Richard E. Green Leanne Haggerty Kendra Hoekzema Thibaut Hourlier Hanlee P. Ji Eimear E. Kenny Barbara A. Koenig Alexey Kolesnikov Jan O. Korbel Jennifer Kordosky Sergey Koren HoJoon Lee Alexandra P. Lewis Hugo Magalhães Santiago Marco‐Sola Pierre Marijon Ann M. Mc Cartney Jennifer McDaniel Jacquelyn Mountcastle Maria Nattestad Sergey Nurk Nathan D. Olson Alice B. Popejoy Daniela Puiu Mikko Rautiainen Allison Regier Arang Rhie Samuel Sacco Ashley D. Sanders Valérie Schneider Baergen I. Schultz Kishwar Shafin Michael W. Smith Heidi J. Sofia Ahmad Abou Tayoun Françoise Thibaud‐Nissen Francesca Floriana Tricomi

Abstract Here the Human Pangenome Reference Consortium presents a first draft of human pangenome reference. The contains 47 phased, diploid assemblies from cohort genetically diverse individuals 1 . These cover more than 99% expected sequence in each genome and are accurate at structural base pair levels. Based on alignments assemblies, we generate that captures known variants haplotypes reveals new alleles structurally complex loci. We also add 119 million pairs euchromatic polymorphic...

10.1038/s41586-023-05896-x article EN cc-by Nature 2023-05-10

Abstract Background The American College of Medical Genetics and Genomics (ACMG)/Association for Molecular Pathology (AMP) clinical variant interpretation guidelines established criteria different types evidence. This includes the strong evidence codes PS3 BS3 “well-established” functional assays demonstrating a has abnormal or normal gene/protein function, respectively. However, they did not provide detailed guidance on how should be evaluated, differences in application PS3/BS3 are...

10.1186/s13073-019-0690-2 article EN cc-by Genome Medicine 2019-12-31

Due to the high genetic heterogeneity of hearing loss (HL), current clinical testing includes sequencing large numbers genes, which often yields a significant number novel variants. Therefore, standardization variant interpretation is crucial provide consistent and accurate diagnoses. The Hearing Loss Variant Curation Expert Panel was created within Clinical Genome Resource expert guidance for standardized genomic in context HL. As one its major tasks, our has adapted American College...

10.1002/humu.23630 article EN Human Mutation 2018-10-11

Recommendations from the American College of Medical Genetics and Genomics Association for Molecular Pathology (ACMG/AMP) interpreting sequence variants specify use computational predictors as "supporting" level evidence pathogenicity or benignity using criteria PP3 BP4, respectively. However, score intervals defined by tool developers, ACMG/AMP recommendations that require consensus multiple predictors, lack quantitative support. Previously, we described a probabilistic framework quantified...

10.1016/j.ajhg.2022.10.013 article EN cc-by The American Journal of Human Genetics 2022-11-21
Daniela Matuozzo Estelle Talouarn Astrid Marchal Peng Zhang Jérémy Manry and 95 more Yoann Seeleuthner Yu Zhang Alexandre Bolze Matthieu Chaldebas Baptiste Milisavljevic Adrian Gervais Paul Bastard Takaki Asano Lucy Bizien Federica Barzaghi Hassan Abolhassani Ahmad Abou Tayoun Alessandro Aiuti Ilad Alavi Darazam Luis M. Allende Rebeca Alonso‐Arias Andrés A. Arias Gökhan Aytekіn Peter Bergman Simone Bondesan Yenan T. Bryceson Ingrid G. Bustos Óscar Cabrera-Marante Sheila Cárcel Paola Carrera Giorgio Casari Khalil Chaïbi Roger Colobrán Antônio Condino‐Neto Laura Covill Ottavia M. Delmonte Loubna El Zein Carlos Flores Peter K. Gregersen Marta Gut Filomeen Haerynck Rabih Halwani Selda Hançerli Lennart Hammarström Nevin Hatipoğlu Adem Karbuz Sevgi Keleş Christèle Kyheng Rafael León‐López José Luis Franco Davood Mansouri Javier Martínez‐Picado Özge Metin Akcan Isabelle Migeotte Pierre‐Emmanuel Morange Guillaume Morelle Andrea Martín-Nalda Giuseppe Novelli Antonio Novelli Tayfun Özçelık Figen Palabıyık Qiang Pan‐Hammarström Rebeca Pérez de Diego Laura Planas‐Serra Daniel E. Pleguezuelo Carolina Prando Aurora Pujol Luis Felipe Reyes Jacques G. Rivière Carlos Rodríguez‐Gallego Julián Rojas Patrizia Rovere‐Querini Agatha Schlüter Mohammad Shahrooei Ali Sobh Pere Soler‐Palacín Yacine Tandjaoui-Lambiotte Imran Tipu Cristina Tresoldi Jesús Troya Diederik van de Beek Mayana Zatz Paweł Zawadzki Saleh Zaid Al-Muhsen Mohammed F. Alosaimi Fahad Alsohime Hagit Baris Feldman Manish J. Butte Stefan N. Constantinescu Megan A. Cooper Clifton L. Dalgard Jacques Fellay James R. Heath YL Lau Richard P. Lifton Tom Maniatis Trine H. Mogensen Horst von Bernuth Alban Lermine Michel Vidaud

Abstract Background We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent interferon (IFN) immunity or autoantibodies against IFN, account for 15–20% cases life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants remain be identified ~ 80% cases. Methods report here a genome-wide rare variant burden association analysis 3269 patients with COVID-19, 1373 SARS-CoV-2-infected individuals without pneumonia. Among 928...

10.1186/s13073-023-01173-8 article EN cc-by Genome Medicine 2023-04-05

The ongoing COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. Age, smoking, obesity, and chronic diseases such as cardiovascular disease diabetes have been described risk factors for severe complications mortality in COVID-19. Obesity are usually associated with dysregulated lipid synthesis clearance, which can initiate or aggravate pulmonary inflammation injury. It has shown that viral entry into host cell, SARS-CoV-2 utilizes angiotensin-converting enzyme 2 (ACE2) receptors...

10.3389/fphys.2020.555039 article EN cc-by Frontiers in Physiology 2020-09-18

Characterizing key molecular and cellular pathways involved in COVID-19 is essential for disease prognosis management. We perform shotgun transcriptome sequencing of human RNA obtained from nasopharyngeal swabs patients with COVID-19, identify a signature associated severity. Specifically, we globally dysregulated immune related pathways, such as cytokine-cytokine receptor signaling, complement coagulation cascades, JAK-STAT, TGF- β signaling all, though to higher extent severe symptoms. The...

10.1016/j.csbj.2020.12.016 article EN cc-by-nc-nd Computational and Structural Biotechnology Journal 2020-12-18

Abstract Background Rare diseases collectively impose a significant burden on healthcare systems, especially in underserved regions, like the Middle East, which lack access to genomic diagnostic services and associated personalized management plans. Methods We established clinical genomics genetic counseling facility, within multidisciplinary tertiary pediatric center, United Arab Emirates locally diagnose manage patients with rare diseases. Clinical investigations included exome-based...

10.1186/s13073-023-01157-8 article EN cc-by Genome Medicine 2023-01-27
Maninder Kaur Justin Blair Batsal Devkota Sierra Fortunato Dinah Clark and 92 more Audrey Lawrence Jiwoo Kim Wonwook Do Benjamin Semeo Olivia Katz Devanshi Mehta Nobuko Yamamoto Emma Schindler Zayd Al Rawi Nina Wallace Jonathan J. Wilde Jennifer McCallum Jinglan Liu Dongbin Xu Marie Jackson Stefan Rentas Ahmad Abou Tayoun Zhe Zhang Omar Abdul‐Rahman Bill Allen Moris A. Angula Kwame Anyane‐Yeboa Jesús Argente Pamela Arn Linlea Armstrong Lina Basel‐Salmon Gareth Baynam Lynne M. Bird Daniel E. Bruegger Gaik‐Siew Ch'ng David Chitayat Robin D. Clark Gerald F. Cox Usha Dave Elfrede DeBaere Michael Field John M. Graham Karen W. Gripp Robert M. Greenstein Neerja Gupta Randy Heidenreich Jodi D. Hoffman Robert J. Hopkin Kenneth Lyons Jones Marilyn C. Jones Ariana Kariminejad Jillene Kogan Baiba Lāce J. G. Leroy Sally Ann Lynch Marie McDonald Kirsten Meagher Nancy J. Mendelsohn Ieva Mičule John B. Moeschler Sheela Nampoothiri Kaoru Ohashi Cynthia M. Powell Subhadra Ramanathan Salmo Raskin Elizabeth Roeder Marlène Rio Alan F. Rope Karan Sangha Angela E. Scheuerle Adele Schneider Stavit A. Shalev Victoria Mok Siu Rosemarie Smith Cathy A. Stevens Tinatin Tkemaladze John Toimie Helga V. Toriello Anne‐Marie W. Turner Patricia G. Wheeler Susan M. White Terri L. Young Kathleen M. Loomes Mary Pipan Ann T. Harrington Elaine H. Zackai Ramakrishnan Rajagopalan Laura K. Conlin Matthew A. Deardorff Deborah McEldrew Juan Pié Feliciano J. Ramos Antonio Musio Antonie D. Kline Kosuke Izumi Sarah E. Raible Ian D. Krantz

Abstract Cornelia de Lange Syndrome (CdLS) is a rare, dominantly inherited multisystem developmental disorder characterized by highly variable manifestations of growth and delays, upper limb involvement, hypertrichosis, cardiac, gastrointestinal, craniofacial, other systemic features. Pathogenic variants in genes encoding cohesin complex structural subunits regulatory proteins (NIPBL, SMC1A, SMC3, HDAC8, RAD21) are the major pathogenic contributors to CdLS. Heterozygous or hemizygous these...

10.1002/ajmg.a.63247 article EN American Journal of Medical Genetics Part A 2023-06-28

With ongoing improvements in the detection of complex genomic and epigenomic variations, long-read sequencing (LRS) technologies could serve as a unified platform for clinical genetic testing, particularly rare disease settings, where nearly half patients remain undiagnosed using existing technologies. Here, we report simplified funnel-down filtration strategy aimed at enhancing identification small large deleterious variants well abnormal episignature profiles from whole-genome LRS data....

10.1038/s41467-025-57695-9 article EN cc-by-nc-nd Nature Communications 2025-03-14

Clinical exome sequencing (CES) has a reported diagnostic yield of 20% to 30% for most clinical indications. The ongoing discovery novel gene-disease and variant-disease associations are expected increase the CES. Performing systematic reanalysis previously nondiagnostic CES samples represents significant challenge laboratories. Here, we present results automated methodology applied 300 initially analyzed between June 2014 September 2016. Application our reduced variant analysis burden by...

10.1016/j.jmoldx.2018.07.008 article EN cc-by-nc-nd Journal of Molecular Diagnostics 2018-12-18

Abstract Background Spinal muscular atrophy (SMA) is a fatal autosomal recessive disorder for which several treatment options, including gene therapy, have become available. SMA incidence has not been well-characterized in most Arab countries where rates of consanguinity are high. Understanding disease epidemiology important implications screening, prevention, and those populations. Methods We perform diagnostic testing clinical multi-national patient cohort ( N = 171) referred hypotonia...

10.1038/s43856-024-00548-1 article EN cc-by Communications Medicine 2024-06-15
Yi‐Hao Chan Vanja Lundberg Jérémie Le Pen Jiayi Yuan Danyel Lee and 95 more Francesca Pinci Stefano Volpi Koji Nakajima Vincent Bondet Sanna Åkesson Noopur V. Khobrekar Aaron Bodansky Likun Du Tina Melander Alice-Andrée Mariaggi Yoann Seeleuthner Tariq Shikh Saleh Debanjana Chakravarty Per Marits Kerry Dobbs Sofie Vonlanthen Viktoria Hennings Karolina Thörn Darawan Rinchai Lucy Bizien Matthieu Chaldebas Ali Sobh Tayfun Özçelık Sevgi Keleş Suzan A. AlKhater Carolina Prando Isabelle Meyts Paul Bastard A. Borghesi Aziz Bousfiha Oksana Boyarchuk Petter Brodin Jacinta Bustamante Giorgio Casari Rémi Chevalier John Christodoulou Roger Colobrán Antônio Condino‐Neto Juan Carlos Aldave Becerra Lisa M. Arkin Evangelos Andreakos Christian W. Thorball Sara Espinosa Carlos Flores Amyrath Geraldo Rabih Halwani Nevin Hatipoğlu Brahim Melaiki Jacques Fellay Alenka Gagro Yuval Itan Chandima Jeewandara Filomeen Haerynck Davood Mansouri Leslie Naesens Lisa F. P. Ng Keisuke Okamoto Pere Soler‐Palacín Laurent Rénia Aurora Pujol Onofre Igor Resnick José Luis Franco Restrepo Jacques G. Rivière Anna Scherbina Anna Šedivá Mikko Seppänen Helen C. Su Stuart G. Tangye Şehime Gülsün Temel Ahmad Abou Tayoun Stuart E. Turvey K. M. Furkan Uddin Diederik van de Beek Tom Le Voyer Donald C. Vinh Shen‐Ying Zhang Jean‐Laurent Casanova Michael R. Wilson Jérémie Rosain Emmanuelle Jouanguy Mélodie Aubart Laurent Abel Trine H. Mogensen Qiang Pan‐Hammarström Daxing Gao Darragh Duffy Aurélie Cobat Stefan Berg Luigi D. Notarangelo Oliver Harschnitz Charles M. Rice Lorenz Studer Jean‐Laurent Casanova Olov Ekwall Shen‐Ying Zhang

Inherited deficiency of the RNA lariat–debranching enzyme 1 (DBR1) is a rare etiology brainstem viral encephalitis. The cellular basis disease and range predisposition are unclear. We report inherited DBR1 in 14-year-old boy who suffered from isolated SARS-CoV-2 patient homozygous for previously reported hypomorphic pathogenic variant (I120T). Consistently, I120T/I120T fibroblasts affected individuals this another unrelated kindred have similarly low levels protein high lariats. human...

10.1084/jem.20231725 article EN cc-by The Journal of Experimental Medicine 2024-07-18
Coming Soon ...